Clinical Trials on Scleral Lens Wearers in Colombia

Total 31 results

Vivid Laser Center
Sengi

Recruiting

Patient Satisfaction and Visual Outcomes After Bilateral PanOptix Implantation in Patients With Previous Multifocal Contact Lens

Cataract

Canada
Thomas Nagy
Sengi

Terminated

Visual Outcomes and Patient Satisfaction After Bilateral Implantation of Non-diffractive EDOF IOL Made of a New Hydrophobic Acrylic Material

Cataract

Canada
Alcon Research

Terminated

Visual Function With Contralateral AcrySof® ReSTOR® Aspheric SN6AD1 and SN6AD3

Cataract

Canada
Valley Laser Eye Centre
Sengi

Recruiting

Refractive Accuracy of Argos in Conjunction With the Alcon Vision Suite Following Implantation of Presbyopia Correcting IOLs

Cataract

Canada
Alcon Research

Completed

A Clinical Study of the ACRYSOF® IQ EDF Intraocular Lens (IOL)

Cataract

Australia, Spain, Canada, United Kingdom
University of British Columbia

Withdrawn

Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus

Macular Edema Following Cataract Surgery

Canada
University of Missouri-Columbia

Completed

The Effect of Horizant (Gabapentin Enacarbil) on Augmentation (XP-IIT-0034)

Restless Legs Syndrome

United States
XenoPort, Inc.

Withdrawn

A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS (RLS)

RLS

United States
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI); National Center for Complementary... and other collaborators

Completed

Age-Related Eye Disease Study 2 (AREDS2) (AREDS2)

Age-related Macular Degeneration | Cataract

United States
Walter Reed Army Medical Center
AirCast LLC

Completed

Sequential Compression Devices for Treatment of Restless Legs Syndrome

Restless Legs Syndrome

United States
XenoPort, Inc.

Recruiting

An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS (RLS)

RLS

United States
Noctrix Health, Inc.

Recruiting

A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS (THRIVE)

Restless Legs Syndrome

United States
XenoPort, Inc.

Completed

Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
Kowa Research Institute, Inc.

Recruiting

A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Fuchs Endothelial Corneal Dystrophy

United States, United Kingdom, Spain, Germany, Canada, Denmark
Noctrix Health, Inc.

Completed

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

Restless Legs Syndrome

United States
GlaxoSmithKline

Completed

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
GlaxoSmithKline

Completed

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome ((CR-RLS))

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
GlaxoSmithKline

Completed

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
Noctrix Health, Inc.

Completed

Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

Restless Legs Syndrome

United States
GlaxoSmithKline

Completed

Ropinirole Tablets In Young Patients With Restless Legs Syndrome

Restless Legs Syndrome

United States, Belgium, France
UCB BIOSCIENCES, Inc.

Completed

Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome

Restless Legs Syndrome

United States
Boehringer Ingelheim

Completed

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
GlaxoSmithKline

Completed

Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome

Restless Legs Syndrome

United States, Canada
GlaxoSmithKline

Completed

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

Restless Legs Syndrome

United States, Canada
Amgen

Completed

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Cancer | Cataract | Prostate Cancer | Osteoporosis | Osteopenia | Low Bone Mineral Density

United States, Canada, Czechia, Poland, Russian Federation, Slovakia, Hungary, South Africa, Greece, Bulgaria, France, Ukraine, Australia, Latvia, India, Slovenia, New Zealand, Mexico
Impax Laboratories, LLC

Completed

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
XenoPort, Inc.

Completed

Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study (CONCORD)

Restless Legs Syndrome

United States
Centre Hospitalier Universitaire, Amiens

Completed

Place of Antibiotics in the Postoperative Acute Lithiasic Cholecystitis (ABCAL)

Acute Lithiasic Cholecystitis Grade I or II | Symptoms Lasting for Less Than 5 Days | Required Cholecystectomy | Preoperative Amoxicillin Clavulanic Acid for at Most 5 Days

France
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance

Restless Legs Syndrome

United States
GlaxoSmithKline

Completed

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
Boehringer Ingelheim

Completed

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

Restless Legs Syndrome

United States

3

Subscribe